Company

We unite science, technology and talent to get ahead of disease together.

We are GSK

Scroll to explore

Ahead Together

Getting ahead of disease is one of the most inspiring challenges there is on the planet.

We aim to positively impact the health of 2.5 billion people by the end of the decade.

Getting ahead of disease in markets worldwide Outstanding people GSK people Innovation strategic global R&D hubs in US, UK and Belgium vaccines and medicines in development in the Access to Medicine Index for 8th consecutive time Performance group turnover in 2023, AER 3% CER 5%

Our leadership team

Find out more about our board and global leadership team who have overall responsibility for delivering our ambition, strategy and culture.

Leadership team members chatting

Meet our leaders

Policy positions

We have policies in place across GSK to ensure we meet the high standards we set ourselves as a company, and those that are expected of us externally.

Two scientists in a lab

Pricing and access

Doctor in a hospital

Global health and health security

Solar panels with a rainbow in Irvine

Environment

R&<a href=D lab scientists collaborating" width="" height="" />

Ethical standards

Man using a pipette in a lab

Research and development

Scientist working with 3D images in screening lab

Intellectual property

Behind the science

Discover how we're getting ahead

‘Putting patients first means caring about the air they breathe – and reducing the impact of respiratory care on the environment’

‘My cough interferes with everything’: New research could help refractory chronic cough patients after decades of depression, pain, and sleep loss

Remission could be possible for people with asthma, giving them a new outlook on life

6 in 10 of adults over 50 have never heard of RSV, despite some being among those most at risk of infection

‘This could be a golden moment’: Is prevention the ‘medicine’ we need to end the HIV epidemic?

'Scientists need rich and accessible data at scale to make the best possible impact for patients’

‘We’ve seen an explosion in computing power’: Using AI, machine learning and data to unlock the mysteries of disease

Advanced technology is increasing the chances of improving outcomes for cancer patients

‘Global health progress is vital for millions of lives, but it isn’t going fast enough. Here’s what we need to do to get things back on track’

‘It’s insidious and it’s getting worse’: AMR and the urgent need for novel antibiotics

Tony Wood

Our leading scientists

Meet the world-leading scientists who are uniting science, technology and talent to get ahead of disease together.

Outstanding people

Our people are central to our success. That’s why we’re inspired to help the most diverse and outstanding talent to thrive and be happy at work, in a culture where we’re ambitious for patients, accountable for impact and do the right thing.

Great place to work

Meet Tammeka, a change maker, innovator and equality advocate, working to end HIV

Meet Andy: how a life-changing diagnosis changed his career

Veterans at GSK

Araba

Innovating together 2022

Meet Katie – using big data to help more patients.

You might also like

GSK Tech Human Image

Purpose, strategy and culture

At GSK we unite science, technology and talent to get ahead of disease together

Lab worker smiling

Responsibility

To get ahead of disease in the right way means being conscious of the impact we have on the world around us

Glaxo packing room at Bunnythorpe, New Zealand, c.1920

History and heritage

It began when Plough Court Pharmacy was established in 1715. Discover GSK’s journey to the company we are today

This is our global website, intended for visitors seeking information on GSK's worldwide business. Our market sites can be reached by visiting our location selector.

© 2001-2024 GSK plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies.

GSK plc. Registered in England and Wales No. 3888792.

Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.